Company

Qubiotech

Qubiotech Health Intelligence is a company dedicated to the development and commercialization of software for advanced processing and quantification of medical images.

The company was founded in December 2014, based on the transfer of a Positron Emission Tomography (PET) image quantification algorithm developed by the Nuclear Medicine and Molecular Imaging Research Group of the Health Research Institute Foundation in Santiago de Compostela, Spain.

Scientific collaborations

Ramón Domínguez Foundation

Qubiotech Health Intelligence SL maintains a close relationship and collaboration agreements in R&D with the Experimental Molecular Imaging Unit (UNIME-IDIS). The platform is located at the Nuclear Medicine Service of the Hospital Clínico in Santiago de Compostela, and has the necessary technology to perform preclinical and anatomical functional imaging studies. UNIME is managed by the Molecular Imaging Group of IDIS, led by Prof. Dr. Alvaro Ruibal and Dr. Pablo Aguiar.

Cyber BBN

Qubiotech collaborates with the GIB-UB research group led by Dr. Pavia in the PET-AC project, selected in the fourth call for Transfer Projects of the Center for Networked Biomedical Research (CIBER-BBN).

The aim of this project is to improve our current Neurocloud-PET product with new clinically validated functions, of special interest in the early detection of Alzheimer’s disease.

Contributors

Neurocloud is the new paradigm in diagnostic imaging

Increased neuroimaging processing enables better diagnostics in more efficient organizations